Significance of Histological Response to Preoperative Chemoradiotherapy for Pancreatic Cancer

[1]  J. Ajani,et al.  Long-term outcome of phase II trial evaluating chemotherapy, chemoradiotherapy, and surgery for locoregionally advanced esophageal cancer. , 2003, International journal of radiation oncology, biology, physics.

[2]  K. Yamasawa,et al.  p53 alteration is not an independent prognostic indicator, but affects the efficacy of adjuvant chemotherapy in human pancreatic cancer , 2003, Journal of surgical oncology.

[3]  J. Abbruzzese,et al.  Epidermal growth factor receptor-targeted therapy for pancreatic cancer. , 2002, Seminars in oncology.

[4]  W. Regine,et al.  Influence of p53 status on radiation and 5-flourouracil synergy in pancreatic cancer cells. , 2002, Anticancer research.

[5]  R. Bell,et al.  Myofibroblasts are responsible for the desmoplastic reaction surrounding human pancreatic carcinomas. , 2002, Surgery.

[6]  M. Anscher,et al.  Complete Response to Neoadjuvant Chemoradiation for Rectal Cancer Does Not Influence Survival , 2001, Annals of Surgical Oncology.

[7]  E. Paulson,et al.  Neoadjuvant Chemoradiation for Localized Adenocarcinoma of the Pancreas , 2001, Annals of Surgical Oncology.

[8]  D. Kerr,et al.  Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial , 2001, The Lancet.

[9]  E. Paulson,et al.  Staging of pancreatic cancer before and after neoadjuvant chemoradiation , 2001, Journal of Gastrointestinal Surgery.

[10]  K. Lillemoe,et al.  Resected adenocarcinoma of the pancreas— 616 patients: Results, outcomes, and prognostic indicators , 2000, Journal of Gastrointestinal Surgery.

[11]  J. Jeekel,et al.  Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cancer cooperative group. , 1999, Annals of surgery.

[12]  J. Ajani,et al.  Prognostic implications of response to preoperative infusional chemoradiation in locally advanced rectal cancer. , 1999, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[13]  T. Breslin,et al.  Neoadjuvant chemoradiation for adenocarcinoma of the pancreas. , 1998, Frontiers in bioscience : a journal and virtual library.

[14]  Y. Nio,et al.  Clinicopathological significance of epidermal growth factor and its receptor in human pancreatic cancer. , 1997, Anticancer research.

[15]  S. Sumi,et al.  p53 protein expression as prognostic factor in human pancreatic cancer. , 1997, Anticancer research.

[16]  D. V. Von Hoff,et al.  Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  Jeffrey E. Lee,et al.  Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  F. Ames,et al.  Preoperative chemoradiation and pancreaticoduodenectomy for adenocarcinoma of the pancreas. , 1992, Archives of surgery.

[19]  S. Ellenberg,et al.  Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection. , 1985, Archives of surgery.

[20]  R. Hruban,et al.  Exploring the host desmoplastic response to pancreatic carcinoma: gene expression of stromal and neoplastic cells at the site of primary invasion. , 2002, The American journal of pathology.

[21]  J. Ajani,et al.  Response to neoadjuvant chemotherapy best predicts survival after curative resection of gastric cancer. , 1999, Annals of surgery.

[22]  S. Lipsitz,et al.  Phase II trial of preoperative radiation therapy and chemotherapy for patients with localized, resectable adenocarcinoma of the pancreas: an Eastern Cooperative Oncology Group Study. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  Y. Shimosato,et al.  Histological Evaluation of Effects of Radiotherapy and Chemotherapy for carcinomas , 1971 .